Cargando…

Habitual exercise decreases plasma xanthine oxidoreductase activity in middle-aged and older women

The aim of present study was to investigate the association between plasma xanthine oxidoreductase activity, which has gained attention as a novel preventive target of cardiovascular disease, and various physiological parameters and was to determine the effects of habitual exercise on plasma xanthin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosaki, Keisei, Kamijo-Ikemori, Atsuko, Sugaya, Takeshi, Tanahashi, Koichiro, Akazawa, Nobuhiko, Hibi, Chihiro, Nakamura, Takashi, Murase, Takayo, Kimura, Kenjiro, Shibagaki, Yugo, Maeda, Seiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	the Society for Free Radical Research Japan 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990402/ https://www.ncbi.nlm.nih.gov/pubmed/29892164 http://dx.doi.org/10.3164/jcbn.17-101

Ejemplares similares

Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study
por: Kosaki, Keisei, et al.
Publicado: (2022)

Relationship between Urinary Liver-Type Fatty Acid-Binding Protein (L-FABP) and Sarcopenia in Spontaneously Diabetic Torii Fatty Rats
por: Tanabe, Jun, et al.
Publicado: (2020)

Clinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repair
por: Obata, Yumi, et al.
Publicado: (2015)

Distinct Roles of Urinary Liver-Type Fatty Acid-Binding Protein in Non-Diabetic Patients with Anemia
por: Imai, Naohiko, et al.
Publicado: (2015)

Xanthine oxidoreductase activity is correlated with hepatic steatosis
por: Yagi, Chisako, et al.
Publicado: (2022)

Elevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2015)

Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate–salt hypertension
por: Hisamichi, Mikako, et al.
Publicado: (2017)

Aerobic exercise training enhances cerebrovascular pulsatility response to acute aerobic exercise in older adults
por: Akazawa, Nobuhiko, et al.
Publicado: (2018)

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice
por: Nakamura, Takashi, et al.
Publicado: (2021)

Role of High Physical Fitness in Deterioration of Male Sexual Function in Japanese Adult Men
por: Kumagai, Hiroshi, et al.
Publicado: (2019)

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
por: Furuhashi, Masato, et al.
Publicado: (2019)

Gender Differences in the Impact of Plasma Xanthine Oxidoreductase Activity on Coronary Artery Spasm
por: Watanabe, Ken, et al.
Publicado: (2021)

Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease
por: Shimizu, Megumi, et al.
Publicado: (2023)

Plasma Xanthine Oxidoreductase (XOR) Activity in Cardiovascular Disease Outpatients
por: Matsushita, Masato, et al.
Publicado: (2020)

Sedentary behaviour, physical activity, and renal function in older adults: isotemporal substitution modelling
por: Kosaki, Keisei, et al.
Publicado: (2020)

Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients
por: Nakatani, Ayumi, et al.
Publicado: (2017)

Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction
por: Watanabe, Ken, et al.
Publicado: (2020)

Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment
por: Kawachi, Yusuke, et al.
Publicado: (2020)

Relationship between Xanthine Oxidoreductase Redox and Oxidative Stress among Chronic Kidney Disease Patients
por: Terawaki, Hiroyuki, et al.
Publicado: (2018)

Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
por: Okuyama, Tomoko, et al.
Publicado: (2021)

Albuminuria and Renal Pathology in Right Heart Failure: Congestive Kidney?
por: Terashita, Maho, et al.
Publicado: (2022)

Time‐dependent changes in plasma xanthine oxidoreductase during hospitalization of acute heart failure
por: Okazaki, Hirotake, et al.
Publicado: (2020)

Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia
por: Shirai, Sayuri, et al.
Publicado: (2019)

Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees
por: Kurajoh, Masafumi, et al.
Publicado: (2022)

A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases
por: Sato, Ken, et al.
Publicado: (2023)

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients
por: Fujimura, Yuki, et al.
Publicado: (2017)

Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care
por: Okazaki, Hirotake, et al.
Publicado: (2019)

Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease
por: Hiraga, Takashi, et al.
Publicado: (2022)

Angiotensin II type 1a receptor loss ameliorates chronic tubulointerstitial damage after renal ischemia reperfusion
por: Fujita, Yoko, et al.
Publicado: (2021)

Angiotensin II type 1a receptor deficiency alleviates muscle atrophy after denervation
por: Takayama, Suguru, et al.
Publicado: (2023)

Impact of Plasma Xanthine Oxidoreductase Activity on the Mechanisms of Distal Symmetric Polyneuropathy Development in Patients with Type 2 Diabetes
por: Fujishiro, Midori, et al.
Publicado: (2021)

Association of plasma xanthine oxidoreductase activity with blood pressure affected by oxidative stress level: MedCity21 health examination registry
por: Yoshida, Shio, et al.
Publicado: (2020)

Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention
por: Sato, Ryota, et al.
Publicado: (2021)

Pro-Aging Effects of Xanthine Oxidoreductase Products
por: Battelli, Maria Giulia, et al.
Publicado: (2020)

Discriminating Susceptibility of Xanthine Oxidoreductase Family to Metals
por: Steunou, Anne-Soisig, et al.
Publicado: (2023)

Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase
por: Battelli, Maria Giulia, et al.
Publicado: (2018)

Xanthine oxidoreductase: One enzyme for multiple physiological tasks
por: Bortolotti, Massimo, et al.
Publicado: (2021)

Insulin Resistance Associated with Plasma Xanthine Oxidoreductase Activity Independent of Visceral Adiposity and Adiponectin Level: MedCity21 Health Examination Registry
por: Kurajoh, Masafumi, et al.
Publicado: (2019)

Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry
por: Kurajoh, Masafumi, et al.
Publicado: (2021)

Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry
por: Kurajoh, Masafumi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_el87p4ag846fr9a5h8bm39ip1d